APPROVED chemotherapy suppliers will need to ensure they know their compounder ID prior to submitting a claim under new regulations controlling the funding of chemotherapy compounded products, the PBS has announced.
Currently, Approved Suppliers have the option to select the 'ZZZ001' compounder ID code where the compounder ID is unknown, but effective 01 Dec 2017 this option disappears.
The new conditions apply to anyone submitting claims for eligible PBS EFC items through PBS Online and claims submitted without a compounder ID will not be paid, the PBS states.
New payment arrangements to TGA-licensed compounders including the $20 component of the compounding fee will be paid based on the compounder ID included within each eligible PBS EFC infusible item.
Under the new arrangements, payments will be based on PBS line-by-line data generated from PBS EFC claims. This change is expected to reduce the administrative burden for TGA-licensed compounders who will no longer be required to submit claims data to the Chemotherapy Compounding Payment Scheme (CCPS) Administration Agency.
TGA-licensed compounders will have until 14 Dec to submit claims to the CCPS Administration Agency for supplies made up to and including 30 Nov 2017.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Sep 17
